Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada
Department of Psychiatry, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
BMJ Open. 2024 May 30;14(5):e074929. doi: 10.1136/bmjopen-2023-074929.
Multiple sclerosis (MS) is an immune-mediated demyelinating disease with a significant burden of neuropsychiatric sequelae. These symptoms, including depression and anxiety, are predictors of morbidity and mortality in people with MS. Despite a high prevalence of obsessive-compulsive disorder in MS, potentially shared pathophysiological mechanisms and overlap in possible treatments, no review has specifically examined the clinical dimensions of people with obsessive-compulsive and related disorders (OCRD) and MS. In this scoping review, we aim to map the available knowledge on the clinical dimensions of people with co-occurring OCRD and MS. Understanding the characteristics of this population in greater detail will inform more patient-centred care and create a framework for future studies.
We developed a search strategy to identify all articles that include people with co-occurring OCRD and MS. The search strategy (extending to the grey literature) was applied to MEDLINE, Embase, PsycINFO, Cochrane Central Register of Controlled Trials, CINAHL, Web of Science and ProQuest Dissertations & Theses. Records will undergo title and abstract screening by two independent reviewers. Articles meeting inclusion criteria based on title and abstract screening will go on to full-text review by the two independent reviewers. After reaching a consensus about articles for inclusion in the final review, data will be extracted using a standardised extraction form. The extracted data will include clinical characteristics of patients such as age, gender, medication use and severity of MS, among others.
This scoping review does not require research ethics approval. Results will be shared at national and/or international conferences, in a peer-reviewed journal publication, in a plain language summary and in a webinar for the general public.
多发性硬化症(MS)是一种免疫介导的脱髓鞘疾病,伴有严重的神经精神后遗症。这些症状,包括抑郁和焦虑,是 MS 患者发病率和死亡率的预测因素。尽管 MS 患者中强迫症的患病率很高,潜在的共同病理生理机制和可能的治疗方法重叠,但没有专门的综述检查同时患有强迫症和相关障碍(OCRD)和 MS 的患者的临床特征。在本次范围综述中,我们旨在绘制关于同时患有 OCRD 和 MS 的患者的临床特征的现有知识图谱。更详细地了解这一人群的特征将为更以患者为中心的护理提供信息,并为未来的研究创建一个框架。
我们制定了搜索策略,以确定包含同时患有 OCRD 和 MS 的患者的所有文章。该搜索策略(扩展到灰色文献)应用于 MEDLINE、Embase、PsycINFO、Cochrane 中央对照试验注册库、CINAHL、Web of Science 和 ProQuest Dissertations & Theses。记录将由两名独立审查员进行标题和摘要筛选。根据标题和摘要筛选符合纳入标准的文章将由两名独立审查员进行全文审查。在就最终综述中纳入的文章达成共识后,将使用标准化的提取表格提取数据。提取的数据将包括患者的临床特征,例如年龄、性别、药物使用和 MS 的严重程度等。
本范围综述不需要研究伦理批准。结果将在国家和/或国际会议上、同行评议的期刊出版物上、大众的通俗易懂的摘要和网络研讨会上分享。